Found 16 matching trials
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
PHASE2The purpose of this randomized, double-blind, placebo-controlled study is t...
Location
Southern Cancer Center
Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1This is a prospective, single-center phase 1 clinical study aimed at determ...
Location
Froedtert Hospital & the Medical College of Wisconsin
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
PHASE1This is an open label, dose escalation study with 3 arms (Arms A, B, and C)...
Location
MD Anderson Cancer Center
SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer
PHASE2RATIONALE: SB939 may stop the growth of tumor cells by blocking some of the...
Location
Tom Baker Cancer Centre
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
PHASE2The purpose of this open label study is to determine whether combining prac...
Location
Southern Cancer Center
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia
PHASE1This research is being done because SB939 has been shown to shrink tumours ...
Location
Alberta Children's Hospital
Study of SB939 in Subjects With Myelofibrosis
PHASE2The goal of this clinical research study is to learn if SB939 can help to c...
Location
UT MD Anderson Cancer Center
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
PHASE2The purpose of this study is to determine the safety and effectiveness of p...
Location
City of Hope Comprehensive Cancer Ctr
A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body
PHASE1The current study is designed to generate data for the investigation of abs...
A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
PHASE2This is a Phase 2, two-stage study of the safety and efficacy of pracinosta...